Followers | 839 |
Posts | 120650 |
Boards Moderated | 13 |
Alias Born | 09/05/2002 |
Tuesday, October 03, 2023 12:55:17 PM
https://finance.yahoo.com/news/aligos-therapeutics-announces-award-8-113000446.html
$8.5M won’t go very far, but I suppose that every little bit helps. ALGS is expected to report data from the phase-1 trial of ALG-097558 in 1H24.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ALGS News
- Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024 • GlobeNewswire Inc. • 10/30/2024 08:05:00 PM
- Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184 • GlobeNewswire Inc. • 10/22/2024 12:00:00 PM
- Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024 • GlobeNewswire Inc. • 10/15/2024 01:00:00 PM
- Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/11/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:16:11 PM
- Aligos Therapeutics Appoints David Perry as Vice President of Business Development • GlobeNewswire Inc. • 10/01/2024 12:00:00 PM
- Aligos Therapeutics to Present at Investor Conferences in October • GlobeNewswire Inc. • 09/30/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 08:15:28 PM
- Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer • GlobeNewswire Inc. • 09/24/2024 12:00:00 PM
- Aligos Therapeutics Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH • GlobeNewswire Inc. • 09/19/2024 12:00:00 PM
- Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024 • GlobeNewswire Inc. • 09/18/2024 09:00:00 PM
- Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/13/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 08:22:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:06:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:59 PM
- Aligos Therapeutics Announces Reverse Stock Split • GlobeNewswire Inc. • 08/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:09:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:08:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:11:01 PM
- Aligos Therapeutics Strengthens Board with Two New Independent Directors • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:14:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:31 PM
- Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/30/2024 08:05:00 PM
- Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd. • GlobeNewswire Inc. • 07/22/2024 01:00:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM